Home › NDC Lookup › RxCUI directory › RxCUI 543801

Benzocaine 0.2 MG/MG Oral Gel [Gingicaine] — RxCUI 543801

RxNorm drug concept · Semantic branded drug
RxCUI 543801 Semantic branded drug · SBD Retired or remapped concept 6 FDA products 14 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI543801
Official nameBenzocaine 0.2 MG/MG Oral Gel [Gingicaine]
Concept typeSemantic branded drug (SBD)
RxNorm statusRetired or remapped concept
FDA products mapped6
Package NDCs mapped14
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web

No related-concept groups were available for this RxCUI in the loaded RxNorm data. That does not prove that no related concepts exist.

📦 FDA Products & Package NDCs

6 products · 14 package NDCs
14 package NDCs map to RxCUI 543801 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10129-0033-01 1 GEL in 1 BOTTLE, PLASTIC (10129-033-01) GingiCaine Gel, Pina Colada Gingi-Pak a Division of the Belport 1993-07-06
10129-0033-05 6 GEL in 1 BOTTLE, PLASTIC (10129-033-05) GingiCaine Gel, Pina Colada Gingi-Pak a Division of the Belport 1993-07-06
10129-0034-01 1 GEL in 1 BOTTLE, PLASTIC (10129-034-01) GingiCaine Gel, Chocolate Mint Gingi-Pak a Division of the Belport 1993-07-06
10129-0034-05 6 GEL in 1 BOTTLE, PLASTIC (10129-034-05) GingiCaine Gel, Chocolate Mint Gingi-Pak a Division of the Belport 1993-07-06
10129-0035-01 1 GEL in 1 BOTTLE, PLASTIC (10129-035-01) GingiCaine Gel Gingi-Pak a Division of the Belport 2001-05-07
10129-0035-03 1 GEL in 1 BOTTLE, PLASTIC (10129-035-03) GingiCaine Gel Gingi-Pak a Division of the Belport 1993-07-06
10129-0035-05 6 GEL in 1 BOTTLE, PLASTIC (10129-035-05) GingiCaine Gel Gingi-Pak a Division of the Belport 1993-07-06
10129-0036-01 1 GEL in 1 BOTTLE, PLASTIC (10129-036-01) Gingicaine Gel Strawberry Gingi-Pak a Division of the Belport 1993-07-06
10129-0036-04 20 GEL in 1 SYRINGE, PLASTIC (10129-036-04) Gingicaine Gel Strawberry Gingi-Pak a Division of the Belport 2018-01-11
10129-0036-05 6 GEL in 1 BOTTLE, PLASTIC (10129-036-05) Gingicaine Gel Strawberry Gingi-Pak a Division of the Belport 1993-07-06
10129-0063-03 1 GEL in 1 BOTTLE, PLASTIC (10129-063-03) GingiCaine Gel, Mint Julep Gingi-Pak a Division of the Belport 1998-07-13
10129-0063-05 6 GEL in 1 BOTTLE, PLASTIC (10129-063-05) GingiCaine Gel, Mint Julep Gingi-Pak a Division of the Belport 1998-07-13
10129-0715-03 1 GEL in 1 BOTTLE, PLASTIC (10129-715-03) GingiCaine gel, Cherry Gingi-Pak a Division of the Belport 1999-06-21
10129-0715-05 6 GEL in 1 BOTTLE, PLASTIC (10129-715-05) GingiCaine gel, Cherry Gingi-Pak a Division of the Belport 1999-06-21
Observed labelers: Gingi-Pak a Division of the Belport (14) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.